People suffering from degenerative disc disease might benefit from stem cell transplants, according to a new report from Mayo Clinic researchers presented during the 30th Annual Meeting of the American Academy of Pain Medicine.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
Researchers from Great Ormond Street Hospital and University College London (UCL) report that they have turned stem cells collected from fat in the abdomen of children into living cartilage.
One of the major causes of hearing loss in mammals is damage to the sound-sensing hair cells in the inner ear.
Scientists have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish on their own, even after being transplanted into laboratory animals modified to mimic liver failure.
New findings on why skeletal muscle stem cells stop dividing and renewing muscle mass during aging points to a unique therapeutic opportunity for managing muscle-wasting conditions in humans, says a new University of Colorado Boulder study.
Researchers have a new theory for how stem cells decide whether to become liver or pancreatic cells during development. A cell’s fate is determined by the nearby presence of a messenger molecule called prostaglandin E2, best known for its role in inflammation and pain.
A new study by researchers at the University of Southern California (USC) not only uncovers new details on how bundles of nerves and arteries interact with stem cells, but also showcases revolutionary techniques for following the cells as they function in living animals.
Advances in neonatal care for preterm infants have greatly increased the chances of survival for these fragile infants. However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), a serious lung disease that is a major cause of death and lifelong complicat
A team bringing together experts and investigators from seven different major California institutions has been awarded $40 million to create a new Center of Excellence in Stem Cell Genomics by the California Institute for Regenerative Medicine (CIRM).
Scientists have long had high hopes for using human embryonic stem cells in treating a variety of diseases and injuries because they are pluripotent, which means they can differentiate into various cell types in the body.